UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000005324 |
|---|---|
| Receipt number | R000006328 |
| Scientific Title | A clinical study on the efficacy and safety of pursuing irradiation in stereotactic body radiotherapy for the lung |
| Date of disclosure of the study information | 2011/06/01 |
| Last modified on | 2015/04/27 20:48:56 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
A clinical study on the efficacy and safety of pursuing irradiation in stereotactic body radiotherapy for the lung
Acronym
The efficacy and safety of pursuing irradiation in SBRT for the lung
Scientific Title
A clinical study on the efficacy and safety of pursuing irradiation in stereotactic body radiotherapy for the lung
Scientific Title:Acronym
The efficacy and safety of pursuing irradiation in SBRT for the lung
Region
| Japan |
Condition
Condition
Lung cancer
Classification by specialty
| Pneumology | Radiology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To confirm the feasibility, efficacy, and safety of the pursuing irradiation in SBRT for the lung cancer
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Feasibility of the protocol treatment
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Maneuver |
Interventions/Control_1
Pursing irradiation in SBRT with 48 Gy or 56Gy in 4 fractions, once a day, twice to four times a week
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Primary or metastatic lung cancer
A. Primary lung cancer;
(1) (a) Prinmary lung cancer, with histological and/or cytological confirmation, (b) clinically or radiologically diagnosed lung cancer
(2) Tumor size </= 5cm, and clinical stage IA or IB
B. Metastatic lung cancer;
(1)Metastatic lung cancer clinically or radiologically diagnosed
(2)Tumor size </=5cm, a single lung lesion, and no lesions other than lung
2) Dose to adjacent organ is not estimated to exceed constraints in pretreatment chest CT
3) Patients' age must be>/=≥20 years old
4) ECOG performance status must be 0-2
5) Patients can lay on their back holding their arms over the heads, and keep that position at least 30 minutes
6) Estimated tumor movement due to respitation >/=5mm
Key exclusion criteria
1) previous irradiation around the lesion
2) With active interstitial pneumonia or pulmonary fibrosis
3) With severe diabetic mellitus or collagen disease
4) Women during pregnancy or lactating , or who might be pregnant
5) With psychiatric illness which impede protocol treatment
6) Patients who are considered to be inappropriate for this study by physicians
Target sample size
35
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Masahiro Hiraoka |
Organization
Graduate School of Medicine, Kyoto University
Division name
Department of Radiation Oncology and Image-applied Therapy
Zip code
Address
54 Shogoin Kawaharacho Sakyo-ku, Kyoto
TEL
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name |
Organization
Graduate School of Medicine, Kyoto University
Division name
Department of Radiation Oncology and Image-applied Therapy
Zip code
Address
TEL
Homepage URL
ymatsuo@kuhp.kyoto-u.ac.jp
Sponsor or person
Institute
Department of Radiation Oncology and Image-applied Therapy, Graduate School of Medicine, Kyoto University
Institute
Department
Personal name
Funding Source
Organization
Funding Program for World-Leading Innovative R&D on Science and Technology
Organization
Division
Category of Funding Organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Mitsubishi Heavy Industries, Ltd
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
京都大学医学部附属病院（京都府）
Other administrative information
Date of disclosure of the study information
| 2011 | Year | 06 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2011 | Year | 03 | Month | 24 | Day |
Date of IRB
Anticipated trial start date
| 2011 | Year | 06 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2011 | Year | 03 | Month | 27 | Day |
Last modified on
| 2015 | Year | 04 | Month | 27 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006328
